Tags : QIAstat-Dx Test Kit

QIAGEN’s QIAstat-Dx Test Kit Receives the US FDA’s EUA as

Shots: QIAGEN has received the FDA’s EUA for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test for diagnosing patients infected with the novel COVID-19 The syndromic test will be deployed in pandemic and can differentiate the SARS-CoV-2 coronavirus from 21 other serious respiratory infections in patients showing similar symptoms. The kit requires < 1min. for […]Read More

QIAGEN Releases QIAstat-Dx Test Kit as the First Syndromic Test

Shots: QIAGEN has started the shipment of its QIAstat-Dx Respiratory SARS-CoV-2 Panel test to the US for diagnosing the patients infected with COVID-19 under a new FDA’s policy, announced on Mar 16, 2020 The QIAstat-Dx test is a multiplexed nucleic acid test that assesses samples such as nasopharyngeal swabs obtained from individuals suspected of the […]Read More